|
|
Volumn 1, Issue 2, 2000, Pages 164-165
|
|
Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
BREAST TUMOR;
DRUG UTILIZATION;
FEMALE;
HUMAN;
LETTER;
METHODOLOGY;
MORTALITY;
ONCOLOGY;
PATIENT SELECTION;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
STATISTICS;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
DRUG UTILIZATION;
FEMALE;
HUMANS;
MEDICAL ONCOLOGY;
PACLITAXEL;
PATIENT SELECTION;
QUALITY OF LIFE;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 0034236356
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.1016/s1526-8209(11)70117-3 Document Type: Letter |
|
Times cited : (1)
|
|
References (17)
|
